Exercise Training in ICD Recipients; Effect on Therapy Delivered, Depression and Anxiety
ETHIC
Exercise Training to Reduce Ventricular Arrhythmia in Heart Failure Patients With ICD - The Ethic Study
2 other identifiers
interventional
40
1 country
1
Brief Summary
Interventional study in patients with ICD. Controlled, open intervention with exercise training. Assessment of changes in physiological and psychological parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Apr 2008
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 22, 2009
CompletedFirst Posted
Study publicly available on registry
December 24, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedAugust 25, 2016
August 1, 2016
4.7 years
December 22, 2009
August 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Therapy delivered from ICD, Anxiety score, functional status
3 months
Secondary Outcomes (1)
HRV, Endothelial function
3 months
Study Arms (2)
Exercise training
EXPERIMENTALtraining
Not training
NO INTERVENTIONNo organized training
Interventions
3 months supervised interval training
Eligibility Criteria
You may not qualify if:
- Planned revascularisation by bypass surgery or percutaneous coronary intervention following the ICD implantation, planned arrhythmia ablation, long QT-syndrome, Brugada syndrome, WPW syndrome, Drug-induced torsades, catecholaminergic polymorphic ventricular tachycardia, Hypertrophic cardiomyopathy right ventricular cardiomyopathy, dilated cardiomyopathy, Aortic stenosis, mitral valve prolapse, anomalous origin of coronary arteries, Myocardial bridging, ongoing myocarditis, recent chest trauma,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Helse Stavanger HFlead
- Stavanger Health Researchcollaborator
Study Sites (1)
Stavanger Health Research
Stavanger, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alf Inge Larsen, MD, PhD
University of Bergen
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2009
First Posted
December 24, 2009
Study Start
April 1, 2008
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
August 25, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share